格隆汇3月20日丨启明医疗-B(02500.HK)公告，于2025年3月20日，公司与认购人杭州盈智勤贰号创业投资合伙企业（有限合伙）订立认购协议，据此，认购人已有条件同意认购，而公司已有条件同意，按每股转换股份初步转换价4.50港元（较于认购协议日期所报的每股H股收市价3.32港元溢价约35.54%）发行本金总额不超过人民币2亿元的可转换债券。
假设所有转换股份按初步转换价每股转换股份4.50港元悉数获转换，则公司将发行合共48,124,527股转换股份，相当于(i)截至本公告日期本公司全部已发行股本的约10.91%；及(ii)经发行转换股份扩大公司全部已发行股本的约9.84%。
集团拟将发行债券的所得款项净额主要用于(i)加快其核心产品管线的开发；(ii)改善集团的资本架构；及(iii)补充一般企业营运资金需求。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.